奶牛乳腺炎防治的免疫学和药理学机制

奶牛乳腺炎是一种复杂的多因素疾病，给世界各国奶牛业造成了巨大的经济损失，而至今未能提出一个彻底解决的办法。本文综述了奶牛乳腺炎的致病因素、乳腺的免疫机制和乳腺炎治疗的药理学机制方面的研究进展，重点剖析了乳腺特殊的免疫体系和乳腺炎治疗的药理学特点，分析阐明了奶牛乳腺炎免疫和治疗失败的原因。     

奶牛乳房炎多联苗(B)的临床免疫试验

用奶牛乳房炎多联苗 (B)免疫家兔 ,14 d血清中金黄色葡萄球菌抗体效价可达 1∶ 8,2 8d抗体水平明显升高 ,可达 1∶ 32 ,注苗后 35 d攻毒 ,攻毒后 2 d保护率为 93.3% (14 /15 ) ,自然保护率为 2 0 % (1/5 ) ,10 d保护率为 6 6 .6 % (10 /15 ) ,自然保护率为 2 0 % (1/5 ) ;用多联苗 (B)臀部肌肉注射免疫泌乳牛 ,试验期间 4个月内 ,3ml剂量组临床型乳房炎月平均发病率为 11.0 9% ,其对照组为 2 0 .19% ,发病率降低 4 5 .2 9% ,差异极显著 (P<0 .0 1) ;5 m l剂量组月平均发病率为 13.0 1% ,其对照组为 31.36 % ,发病率降低 5 8.5 1% ,差异极显著 (P<0 .0 1) ;3ml剂量组与 5 m l剂量组之间发病率无明显差异 (P>0 .0 5 ) ;注苗后泌乳牛血清抗体水平可持续 4个月 ,且 30 d时效价水平最高。     

Inflammation-related changes in cyclic AMP and cyclic GMP in bovine mastitis

Cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) cocentrations in milk and plasma samples from healthy and mastitic cows were determined by radioi-immunoassay and compared with prostaglandins (PGE2, PGF2 and thromboxane B2 [TXB2]), phospholipids and other relevant parameters in milk and blood. The concentrations of cAMP were about five times higher in plasma (p<0.01) than in milk, whereas the cGMP concentration in milk was three times higher (p<0.01) than that in plasma in both healthy and diseased animals. In mastitic milk, the cAMP and cGMP concentrations were 19% and 65% and in blood plasma 13% and 84% higher respectively than in healthy animals. In milk, cyclic nucleotide concentrations correlated with the markedly elevated cell count and also with the prostaglandin concentration and pH. In blood, cAMP correlated positively with phospholipids and cGMP with reduced glutathione (GSH). These changes are considered to be important in the disease process and, in particular, the increase in cGMP deserves further study.     

奶牛隐性乳腺炎病原菌的分离鉴定

用兰州乳房炎试验(LMT)对来自西安市某个牛场的76份奶样作隐性乳房炎检验，并对乳样进行细菌分离鉴定。结果表明，该牛场的隐性乳房炎检出率为33％，阳性乳样中细菌检出率为93．4％。阴性乳样中病原菌检出率为28％，在检出的94株细菌中，共有5种菌22株是与乳房炎有关的病原菌。其中葡萄球菌和链球菌占病原菌总数的90％以上。是引起该场奶牛隐性乳房炎的主要病原菌。     

荷斯坦奶牛隐性乳房炎与乳用特征的相关性分析

随机抽取荷斯坦奶牛 472头 (1～ 11胎 )进行奶牛隐性乳房炎的检测 ,乳用特征性状 (楞角性、尻宽、尻角度、后肢侧视、蹄角度 )的线性评定 ,以及隐性乳房炎与乳用特征的相关性分析。结果表明 :奶牛隐性乳房炎的乳区阳性率与楞角性、尻宽、尻角度、后肢侧视、蹄角度的相关系数分别为 0 1171、0 10 3 0、0 0 681、0 0 180、-0 12 65 ,其中与楞角性、尻宽分别达到显著水平 (P <0 0 5 )的正相关 ,与蹄角度达极显著 (P <0 0 1)的负相关。奶牛阳性率与楞角性、尻宽、尻角度、后肢侧视、蹄角度的相关系数分别为 0 0 967、0 0 5 61、0 0 2 82、0 0 12 7和 -0 0 670 ,其中除与楞角性为显著水平 (P <0 0 5 )的正相关 (0 0 967)外 ,其余均不显著 (P >0 0 5 )。     

Noninferiority trial investigating the efficacy of a nonantibiotic intramammary therapy in the treatment of mild‐to‐moderate clinical mastitis in dairy cows with longer lasting udder diseases

A nonblinded, positively controlled, noninferiority trial was conducted to evaluate the efficacy of an alternative, nonantibiotic therapy with Masti Veyxym^® to reduce ineffective antibiotic usage in the treatment of nonsevere clinical mastitis (CM) in cows with longer lasting udder diseases. The solely intramammary treatment with Masti Veyxym^® (three applications, 12 hr apart) and the combined treatment with Masti Veyxym^® and antibiotics as usual on the farm according to label of the respective product were compared with the reference treatment of solely antibiotic therapy. The matched field study was conducted on eight free‐stall dairy farms located in Eastern Germany. Cases of mild‐to‐moderate CM in cows with longer lasting high somatic cell counts in preceding dairy herd improvement test days and with previous CM cases in current lactation were randomly allocated to one of the three treatment groups. A foremilk sample of the affected quarter was taken before treatment and again approximately 14 days and 21 days after the end of therapy for cyto‐bacteriological examination. Primary outcomes were clinical cure (CC) and no CM recurrence within 60 days after the end of treatment (no R60). Bacteriological cure (BC) and quarter somatic cell count (QSCC) cure were chosen as secondary outcomes although low probabilities of BC and QSCC cure for selected cows were expected. The study resulted in the following findings: the pathogens mostly cultured from pretreatment samples were Streptococcus uberis, followed by Staphylococcus aureus and coagulase‐negative staphylococci. There were no significant differences between the two test treatments in comparison with the reference treatment regarding all outcome variables. The sole therapy with Masti Veyxym^® resulted in a numerically lower likelihood of BC without significant differences to the reference treatment. The combined therapy group showed a numerically higher nonrecurrence rate than the two other treatment groups and noninferiority compared to the reference treatment was proven. Having regard to the selection criteria of cows in this study, the findings indicated that sole treatment with Masti Veyxym^® in nonsevere CM cases may constitute an alternative therapy to reduce antibiotics. However, noninferiority evaluations were mostly inconclusive. Further investigations with a larger sample size are required to confirm the results and to make a clear statement on noninferiority.     

奶牛胃肠道菌群与奶牛乳房炎关联性及其对乳房炎调控潜力的研究进展

乳房炎是严重影响奶牛机体健康状态及乳品质量的疾病之一。一直以来,外源致病菌入侵乳房并引发感染被认为是奶牛乳房炎发病的主要因素。然而,最近的研究表明,胃肠道菌群同样能够影响奶牛乳房炎的发病并对炎症进行调控。其主要机制可能涉及"肠道-乳腺"内源途径,即来自胃肠道的某些细菌可以通过涉及单核免疫细胞（主要是吞噬细胞）机制进行转移,通过内源性细胞途径（细菌性肠-乳途径）迁移到乳腺。本文就奶牛乳房炎的致病因素及其影响、胃肠道菌群与奶牛乳房炎的关联性及其对乳房炎的调控（包括饮食、短链脂肪酸（short-chain fatty acids,SCFAs）、益生菌及共生菌等因素）等方面进行了综述,旨在为奶牛乳房炎的发病机制及缓解措施提供新的思路。     

Diagnosis and treatment of mastitis in mares

Infection and inflammation of the udder (mastitis) is a common condition affecting all domestic mammals, but it appears to be less prevalent in mares than in dairy cows and dairy goats. The seemingly reduced incidence of mastitis in mares can be partially explained by the smaller size and relatively concealed location of the mare’s udder, coupled with a smaller storage capacity than cows and goats. Mastitis can affect lactating, peripartum, dry mares, mares at dry-off or prepubertal foals. Common clinical signs include swollen mammary tissue, abnormal mammary gland secretion, fever and anorexia; less common signs are hindlimb lameness and a swollen mammary vein. On rare occasions, mastitis pathogens can severely affect the nursing foal and mares may develop fibrotic tissue and consequent agalactia in the side(s) or quarter(s) affected. Based on the clinical presentation, mastitis can be classified as acute or chronic, and clinical or subclinical. Diagnosis is based on the clinical signs aided with aerobic culture and cytological evaluation of the gland secretion. In addition, these ancillary tests can also be used to assess prognosis and duration of treatment. Mares suffering from mastitis may present neutrophilia and hyperfibrinogenaemia. Treatment for mastitis includes antimicrobial therapy (systemic and/or locally), nonsteroidal anti-inflammatory drugs, frequent milking and cold hosing with/without hot-packing applied on the gland. While the frequent monitoring of mares after weaning and reducing food intake should be part of common practices at weaning, cleaning of the udder, control of insect populations and frequent milking of mares with a foal unable to nurse can also aid in preventing mastitis.